Publications by authors named "Camille Le Gall"

Claim this Profile
E
Evaluation of a Gel Loaded With M101 on Bone and Peri-Implantitis Healing: An Experimental In Vivo Study.
Céline Stutz, Catherine Petit, Pierre-Yves Gegout, Camille Le Gall, Maria Permuy

Clin Oral Implants Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of nanobodies specific for the human ubiquitin-like ISG15 protein.
Jin Gan, Prachi Dabhade, Charlotte Wijne, William McKibben, Simeon D Draganov, Camille Le Gall

J Biol Chem· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-directed multivalent conjugation of antibodies to ubiquitinated payloads.
Angela F El Hebieshy, Zacharias Wijfjes, Camille M Le Gall, Jim Middelburg, Kim E de Roode

Nat Biomed Eng· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-Cyclooctene-caged-IL-1β immunocytokine-constructs ligated to unmodified nanobodies allow click-2-release-based control of cytokine activity.
Amber Barendrecht, Heleen H C Peeters, Diana Torres-García, M Thierry Shema, Alexi J C Sarris, Camille M Le Gall

RSC Chem Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy.
Xin Liu, Camille Le Gall, Ryan K Alexander, Ella Borgman, Thomas Balligand

Nat Biomed Eng· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-delivery of antigen and adjuvant by site-specific conjugation to dendritic cell-targeted Fab fragments potentiates T cell responses.
Zacharias Wijfjes, Iván Ramos Tomillero, Camille M Le Gall, Eric A W van Dinther, Frederique Turlings

RSC Chem Biol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses.
Xin Liu, Thomas Balligand, Camille Le Gall, Hidde L Ploegh

Proc Natl Acad Sci U S A· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bi-specific antibody engagers for cancer immunotherapy.
Hidde Ploegh, Xin Liu, Camille Le Gall, Ryan Alexander, Ella Borgman

Res Sq· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire.
Thomas Eden, Alessa Z Schaffrath, Janusz Wesolowski, Tobias Stähler, Natalie Tode, Camille M Le Gall

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors.
Zacharias Wijfjes, Floris J van Dalen, Camille M Le Gall, Martijn Verdoes

Mol Pharm· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona

J Immunother Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.
Camille M Le Gall, Johan M S van der Schoot, Iván Ramos-Tomillero, Melek Parlak Khalily, Floris J van Dalen

Bioconjug Chem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering.
Johan M S van der Schoot, Felix L Fennemann, Michael Valente, Yusuf Dolen, Iris M Hagemans, Camille M Le Gall

Sci Adv· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells in cancer immunotherapy.
Camille M Le Gall, Jorieke Weiden, Loek J Eggermont, Carl G Figdor

Nat Mater· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CTLA-4 therapy requires an Fc domain for efficacy.
Jessica R Ingram, Olga S Blomberg, Mohammad Rashidian, Lestat Ali, Scott Garforth, Camille Le Gall

Proc Natl Acad Sci U S A· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.
Mohammad Rashidian, Jessica R Ingram, Michael Dougan, Anushka Dongre, Katherine A Whang, Camille LeGall

J Exp Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis